Workflow
百傲化学(603360) - 2025 Q3 - 季度财报
BIO-CHEMBIO-CHEM(SH:603360)2025-10-29 08:20

Financial Performance - Q3 2025 revenue was CNY 307.19 million, a decrease of 1.77% year-over-year, while year-to-date revenue reached CNY 1.06 billion, an increase of 17.88%[2] - Total profit for Q3 2025 was CNY 38.08 million, down 61.89% year-over-year, and year-to-date profit totaled CNY 152.91 million, a decrease of 46.67%[2] - Net profit attributable to shareholders for Q3 2025 was CNY 33.21 million, a decline of 62.97% year-over-year, with year-to-date net profit at CNY 125.00 million, down 50.83%[2] - Basic earnings per share for Q3 2025 were CNY 0.05, a decrease of 61.54% year-over-year, while year-to-date earnings per share were CNY 0.18, down 50.00%[2] - Net profit for the first three quarters of 2025 was ¥135,722,003.40, a decrease of 46.6% from ¥254,222,021.32 in the same period of 2024[18] - The company reported a total comprehensive income of ¥135,817,733.24 for the first three quarters of 2025, compared to ¥248,258,469.13 in the previous year, a decrease of 45.4%[19] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3.66 billion, an increase of 0.44% compared to the end of the previous year[3] - The company's total assets amounted to ¥3,655,758,357.15, slightly up from ¥3,639,769,869.79 in the previous year[14] - Total liabilities increased to ¥1,577,454,878.85, compared to ¥1,288,572,546.59 in the same period last year, marking a rise of 22.4%[14] - The company's equity attributable to shareholders decreased to ¥1,506,239,379.42 from ¥1,788,474,436.44, a decline of 15.7%[14] Shareholder Information - Shareholders' equity attributable to the parent company was CNY 1.51 billion, a decrease of 15.78% from the end of the previous year[3] - Total number of common shareholders at the end of the reporting period is 23,953[9] - The largest shareholder, Dalian Tongyun Investment Co., Ltd., holds 211,581,520 shares, accounting for 29.96% of total shares[9] - The second largest shareholder, Dalian Guangyao Zhixin Shuhong Enterprise Management Consulting Partnership, holds 182,411,659 shares, representing 25.83%[9] - The company has a total of 14,341,976 shares held by Dalian Sanxin Investment Co., Ltd., representing 2.03% of total shares[9] Cash Flow - Cash flow from operating activities for the year-to-date period was CNY 195.69 million, a decrease of 17.02% compared to the previous year[2] - Cash inflow from operating activities for the first three quarters of 2025 reached approximately $1.06 billion, a significant increase from $739.16 million in the same period of 2024, representing a growth of about 43.6%[21] - Net cash flow from operating activities decreased to $195.69 million in 2025 from $235.84 million in 2024, reflecting a decline of approximately 17%[22] - Total cash inflow from investment activities was $141.52 million in 2025, compared to $127.62 million in 2024, marking an increase of about 10.9%[22] - Net cash flow from investment activities worsened to -$288.47 million in 2025 from -$147.50 million in 2024, indicating a decline in investment performance[22] - Cash inflow from financing activities surged to $1.02 billion in 2025, up from $273.92 million in 2024, representing an increase of approximately 272%[22] - Net cash flow from financing activities improved to $70.06 million in 2025, compared to a negative $150.50 million in 2024, showing a positive turnaround[22] - The company's cash and cash equivalents at the end of Q3 2025 stood at $646.25 million, an increase from $418.18 million at the end of Q3 2024[22] - The total cash outflow from operating activities increased to $867.03 million in 2025 from $503.33 million in 2024, reflecting a rise of approximately 72.3%[22] Operational Costs and Expenses - The significant decline in profits was attributed to increased operating costs and reduced investment income, despite revenue growth in the semiconductor business segment[7] - Total operating costs for the first three quarters of 2025 were ¥911,498,010.69, up 49.4% from ¥610,218,244.99 in the previous year[16] - Research and development expenses increased to ¥54,120,901.18 in the first three quarters of 2025, compared to ¥36,394,316.27 in 2024, reflecting a growth of 48.5%[18] Stock and Share Structure - The company implemented a stock dividend distribution in May 2025, increasing total shares from 504,445,467 to 706,223,654[3] - The company has a total of 5,365,500 shares held in the repurchase special securities account, which accounts for 0.76% of the total share capital[10] - The company has no significant changes in the shareholding structure or related party transactions during the reporting period[11] Accounting and Reporting - The company did not apply new accounting standards for the year 2025, maintaining consistency in financial reporting[23]